Terapi biologik pada pasien Psoriasis  

Oleh:

Thaha, M. Athuf

Jenis: Article from Journal - ilmiah nasional
Dalam koleksi: Jurnal Kedokteran Brawijaya vol. 24 no. 03 (Dec. 2008), page 135-141.
Topik: immunosuppressive therapy; immunomodulatory therapy; genetic engineering; surface receptors; targeted bioiogic agents; biologics.

Ketersediaan

Perpustakaan FK Nomor Panggil: J34.K.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Treatment limitations of current immunosuppressive therapies, and growing understanding of psoriasis pathogenesis on a molecular level have stimulated much interest in the field of immunomodu/atory therapy formanagement of psoriasis. Genetic engineering has allowed the development of proteins that are targeted to specific cell surface receptors. A well over 40 targeted biologic agents are in preclinical and clinical testing for T-celI mediated inflammatory diseases, including psoriasis. It is important that, as a doctor become well educated in biologics, since several of these agents are available for the management of psoriasis.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali